Ausgabe 5/2016
Inhalt (14 Artikel)
Sea-blue histiocytes in acute myeloid leukemia with trisomy 9
Katsuya Yamamoto, Yosuke Minami, Shinichiro Kawamoto, Kimikazu Yakushijin, Tomoe Kikuma, Jun Saegusa, Hiroshi Matsuoka, Hironobu Minami
ADAMTS13: more than a regulator of thrombosis
Yun Feng, Xueyin Li, Juan Xiao, Wei Li, Jing Liu, Xue Zeng, Xi Chen, Suhua Chen
Abnormal histone acetylation of CD8+ T cells in patients with severe aplastic anemia
Weiwei Qi, Li Yan, Chunyan Liu, Rong Fu, Huaquan Wang, Zonghong Shao
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan
Haruhiko Ninomiya, Naoshi Obara, Shigeru Chiba, Kensuke Usuki, Kaichi Nishiwaki, Itaru Matsumura, Tsutomu Shichishima, Shinichiro Okamoto, Jun-ichi Nishimura, Kazuma Ohyashiki, Shinji Nakao, Kiyoshi Ando, Yoshinobu Kanda, Tatsuya Kawaguchi, Hideki Nakakuma, Daisuke Harada, Hirozumi Akiyama, Taroh Kinoshita, Keiya Ozawa, Mitsuhiro Omine, Yuzuru Kanakura
Therapeutic effect of Colla corii asini on improving anemia and hemoglobin compositions in pregnant women with thalassemia
Yanfang Li, Hui He, Lilin Yang, Xiangyi Li, Daocheng Li, Songping Luo
Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms
M. Monika Belickova, Michaela Dostalova Merkerova, Hana Votavova, Jan Valka, Jitka Vesela, Barbora Pejsova, Hana Hajkova, Jiri Klema, Jaroslav Cermak, Anna Jonasova
Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia
Ji Hyun Kwon, Young-il Koh, Sung-soo Yoon, Seonyang Park, Inho Kim
NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value
Patricia Rubio, B. Campos, J. A. Digiorge, M. S. Gallego, A. Medina, J. G. Rossi, M. S. Felice, C. N. Alonso
Clinical features and treatment outcome of Epstein–Barr virus-positive nodal T-cell lymphoma
Ki Sun Jung, Su-Hee Cho, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim
Phase I dose escalation study of high dose carfilzomib monotherapy for Japanese patients with relapsed or refractory multiple myeloma
Shinsuke Iida, Kensei Tobinai, Masafumi Taniwaki, Yoshihisa Shumiya, Toru Nakamura, Takaaki Chou
Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia
Akihisa Hino, Hitoshi Yoshida, Yuma Tada, Midori Koike, Ryota Minami, Hiroaki Masaie, Jun Ishikawa
Co-occurrence of hyperleukocytosis and elevated fibrin–fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia
Kunimoto Ichikawa, Yoko Edahiro, Akihiko Gotoh, Kazuhide Iiduka, Norio Komatsu, Michiaki Koike
Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor
Makiko Uemura, Osamu Imataki, Yasunori Kawachi, Kimihiro Kawakami, Yasuo Hoshijima, Akihito Matsuoka, Norimitsu Kadowaki
Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis
Li Fu, Jingshi Wang, Na Wei, Lin Wu, Yini Wang, Wenqiu Huang, Jia Zhang, Jinli Liu, Zhao Wang